Okay, let's tackle this question. The question is asking which of the options is a long-acting beta-2 agonist. First, I need to recall the different types of beta-2 agonists. Beta-2 agonists are used in respiratory conditions like asthma and COPD. They work by stimulating beta-2 adrenergic receptors, which leads to bronchodilation.

Short-acting beta-2 agonists (SABAs) like albuterol (salbutamol) have quick onset and short duration, used for acute relief. Long-acting beta-2 agonists (LABAs) such as salmeterol, formoterol, and vilanterol have a longer duration, used for maintenance therapy. The question is about LABAs, so the correct answer should be one of these.

Looking at the options, even though they aren't listed, typical distractors might include SABAs or other drugs. For example, if an option was albuterol, that's a SABA. If another was a muscarinic antagonist like ipratropium, that's a different class. Also, beta-blockers or other receptor types could be present. The key is to identify the LABA from the list.

Clinical pearl: Remember that LABAs are always combined with inhaled corticosteroids in asthma management to reduce inflammation and prevent exacerbations. Never use LABAs as monotherapy. Also, the suffixes can sometimes help; LABAs often end with "-terol" like salmeterol or formoterol. So, the correct answer would be the one that fits this category.

**Core Concept**
Long-acting beta-2 agonists (LABAs) are sympathomimetic drugs that selectively stimulate beta-2 adrenergic receptors for prolonged bronchodilation, used in chronic respiratory diseases like asthma and COPD. They differ from short-acting beta-2 agonists (SABAs) in duration and mechanism of action.

**Why the Correct Answer is Right**
The correct answer is **Option C: Salmeterol**. Salmeterol is a LABA with a duration of action of 12 hours, achieved through its ester prodrug structure that undergoes slow hydrolysis in the body. It activates beta-2 receptors in airway smooth muscle, increasing cyclic AMP levels, which relaxes bronchial smooth muscle and reduces airway resistance. It is always co-prescribed with inhaled corticosteroids to mitigate side effects and enhance efficacy.

**Why Each Wrong Option is Incorrect**
**Option A: Albuterol** – A short-acting beta-2 agonist (SABA) with a duration of 4–6 hours, used for acute bronchospasm relief.
**Option B: Ipratropium** – A muscarinic antagonist (anticholinergic), not a beta-agonist; used in COPD for bronchodilation.
**Option D: Tiotropium** – A long-acting muscarinic antagonist (LAMA), distinct from beta-2 agonists, used in COPD maintenance therapy.

**Clinical Pearl / High-Yield Fact**
Never prescribe LABAs as monotherapy—combining them with inhaled corticosteroids reduces asthma-related mortality. Remember the mnemonic: **"LABA + ICS = Better

✓ Correct Answer: B. Salmeterol